Wells Fargo & Company Increases Shockwave Medical (NASDAQ:SWAV) Price Target to $275.00

Shockwave Medical (NASDAQ:SWAV – Get Rating) had its price objective upped by Wells Fargo & Company from $252.00 to $275.00 in a research report report published on Tuesday, The Fly reports. Several other equities research analysts also recently issued reports on SWAV. Canaccord Genuity Group increased their price objective on shares of Shockwave Medical from […]

Related Keywords

United States ,America ,Trinh Phung ,Dan Puckett ,Piper Sandler ,Wells Fargo Company ,Canaccord Genuity Group ,Shockwave Medical Company Profile ,Third Bancorp ,Fifth Third Bancorp ,Life Insurance Co ,Shockwave Medical Inc ,Profund Advisors ,Fulton Bank ,Needham Company ,Shockwave Medical ,Get Rating ,Wells Fargo ,Genuity Group ,Moderate Buy ,Life Insurance ,Shockwave Medical Daily ,Nasdaq Swav ,Swav ,Medical ,Boost Price Target ,